Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | STAT6 | P42226 | 1/20 | 0.48 |
| ▸ | ADK | P55263 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6576944 | 0.90 | ADORA3 (0.51) | ADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL6576646 | 0.89 | ADORA3 (0.50) | ADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL6573819 | 0.86 | ADORA3 (0.63) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6572906 | 0.83 | ADORA3 (0.60) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6575154 | 0.83 | SLC29A1 (0.47) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6576807 | 0.83 | ADORA2A (0.69) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6575163 | 0.83 | SLC29A1 (0.47) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6574959 | 0.82 | ADORA3 (0.62) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6573967 | 0.80 | ADORA3 (0.52) | ADORA3ADORA2AADORA1ADORA2BTSHR | |
| SCHEMBL6572451 | 0.80 | ADORA2A (0.62) | ADORA3ADORA2AADORA1ADORA2BTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1090019-B1 | ADENOSINE DERIVATIVES | GLAXO GROUP LTD (GB) | 2004-09-29 | — | — | EP | disclosed |
| EP-1447407-A1 | Adenosine derivatives | GLAXO GROUP LIMITED (GB) | 2004-08-18 | — | — | EP | disclosed |